Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Forensic Sciences|July 25, 2014
A new method to pair-match metacarpals using bilateral asymmetry and shape analysisClaudia Garrido-Varas, Raveen Rathnasinghe, Tim Thompson, et al.
Scientific Reports|October 1, 2021
The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virusRaveen Rathnasinghe, Sonia Jangra, Lisa Miorin, et al.
Viruses|April 30, 2021
Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter GenesAitor Nogales, Michael Schotsaert, Raveen Rathnasinghe, et al.
Mbio|March 3, 2021
Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse ModelFatima Amanat, Shirin Strohmeier, Raveen Rathnasinghe, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse modelFatima Amanat, Shirin Strohmeier, Raveen Rathnasinghe, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2020
Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 InfectionRaveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, et al.
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination seraSonia Jangra, Chengjin Ye, Raveen Rathnasinghe, et al.
Scientific Reports|November 13, 2021
Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1Raveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, et al.
Emerging Microbes & Infections|October 19, 2020
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infectionRaveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, et al.
Research Square|August 17, 2021
Prophylactic Protection Against Respiratory Viruses Conferred by a Prototype Live Attenuated Influenza Virus VaccineRaveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, et al.
Pageof 5